The rejection of the settlement deal is credit negative for Partners because “it has the potential to limit its affiliation opportunities in Eastern Massachusetts and could lead to increased merger and affiliation activity among competing hospital systems,” according to Moody’s.
The ruling could also curtail the system’s acquisition activity, and it highlights “the greater regulatory oversight Partners operates under, relative to other large hospital systems locally and nationally,” according to Moody’s.
More articles on healthcare finance:
7 recent hospital rating and outlook changes, affirmations
5 CFOs in the headlines this week
UPMC operating income increases to $177M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
